INTERSPECIFIC COMBINATION OF SUBMANDIBULAR ENDODERM AND PANCREATIC MESODERM IN CULTURE - PRELIMINARY INVESTIGATIONS

被引：0
|
作者：
KRAMER, B [1 ]
机构：
[1] UNIV WITWATERSRAND,SCH DENT,DEPT GEN ANAT,JOHANNESBURG 2001,SOUTH AFRICA
来源：
SOUTH AFRICAN JOURNAL OF SCIENCE | 1985年 / 81卷 / 07期
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：384 / 384
页数：1
相关论文
共 50 条
  • [41] Association of 2-O, 3-O desulfated heparin (ODSH) plus combination gemcitabine (G)/nab-paclitaxel (A) with preliminary benefit in untreated metastatic pancreatic cancer
    Sigal, Darren
    Marcus, Stephen G.
    Rosen, Peter J.
    Cohen, Steven J.
    Lee, Peter
    Nguyen, Timmy
    Gribbin, Thomas Edward
    Diez, Pedro Quintana
    Borad, Mitesh J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [42] SECOND-LINE CHEMOTHERAPY WITH GEMCITABINE AND OXALIPLATIN IN COMBINATION WITH LOCO-REGIONAL HYPERTHERMIA (EHY-2000) IN PATIENTS WITH REFRACTORY METASTATIC PANCREATIC CANCER - PRELIMINARY RESULTS OF A PROSPECTIVE TRIAL
    Volovat, Constantin
    Volovat, Simona Ruxandra
    Scripcariu, Viorel
    Miron, Lucian
    ROMANIAN REPORTS IN PHYSICS, 2014, 66 (01) : 166 - 174
  • [43] Preliminary safety data from a randomized multicenter phase Ib/II study of neoadjuvant chemoradiation therapy (CRT) alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic cancer.
    Katz, Matthew H. G.
    Varadhachary, Gauri R.
    Bauer, Todd W.
    Acquavella, Nicolas
    Merchant, Nipun B.
    Le, Tri Minh
    Javle, Milind M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [44] Effects of MEK inhibition alone or in combination with PI3K-mTOR pathway inhibitors in pancreatic ductal adenocarcinoma in vitro and on an innovative ex vivo fresh tumor tissue culture model
    Neuzillet, Cindy
    Tijeras-Raballand, Annemilai
    Sadanandam, Anguraj
    Bourgoin, Pierre
    Bourget, Philippe
    Poudel, Pawan
    Serova, Maria
    De Gramont, Armand
    Ruszniewski, Philippe
    Paradis, Valerie
    Raymond, Eric
    Cros, Jerome
    Hammel, Pascal
    CANCER RESEARCH, 2016, 76
  • [45] Safety, tolerability and preliminary efficacy of CAN04, a first in class monoclonal antibody against IL1RAP, in combination with nab-paclitaxel and gemcitabine (NG) in subjects with pancreatic cancer.
    Awada, Ahmad
    Ochsenreither, Sebastian
    Eefsen, Rikke Loevendahl
    Arnold, Dirk
    Yachnin, Jeffrey
    Pfeiffer, Per
    Jungels, Christiane
    Greil, Richard
    Poulsen, Laurids
    Van Cutsem, Eric
    Thorsson, Lars
    Svedman, Christer
    Garcia-Ribas, Ignacio
    Collignon, Joelle
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] TGF-B1 inhibition with losartan in combination with FOLFIRINOX (F-NOX) in locally advanced pancreatic cancer (LAPC): Preliminary feasibility and R0 resection rates from a prospective phase II study
    Murphy, Janet E.
    Wo, Jennifer Yon-Li
    Ferrone, Cristina
    Jiang, Wenqing
    Yeap, Beow Y.
    Blaszkowsky, Lawrence Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [47] Evaluation of tumor biomarkers in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer treated with the CXCL12 inhibitor NOX-A12 and preliminary safety in combination with PD-1 checkpoint inhibitor pembrolizumab
    Halama, Niels
    Pruefer, Ulrike
    Froemming, Anna
    Beyer, Diana
    Eulberg, Dirk
    Jungnelius, Jarl Ulf
    Mangasarian, Aram
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [48] Evaluation of tumor biomarkers in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer treated with the CXCL12 inhibitor NOX-A12 and preliminary safety in combination with PD-1 checkpoint inhibitor pembrolizumab.
    Halama, Niels
    Pruefer, Ulrike
    Fromming, Anna
    Beyer, Diana
    Eulberg, Dirk
    Jungnelius, Jarl Ulf
    Mangasarian, Aram
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [49] Peptide receptor radionuclide therapy (PRRT) with [177Lu-DOTA0,Tyr3]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model
    Bison, Sander M.
    Pool, Stefan E.
    Koelewijn, Stuart J.
    van der Graaf, Linda M.
    Groen, Harald C.
    Melis, Marleen
    de Jong, Marion
    EJNMMI RESEARCH, 2014, 4 : 1 - 10
  • [50] Peptide receptor radionuclide therapy (PRRT) with [177Lu-DOTA0,Tyr3]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model
    Sander M Bison
    Stefan E Pool
    Stuart J Koelewijn
    Linda M van der Graaf
    Harald C Groen
    Marleen Melis
    Marion de Jong
    EJNMMI Research, 4
12345